JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 168,500 shares, a decline of 44.8% from the February 28th total of 305,100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

JCRRF stock remained flat at $4.57 during trading on Friday. JCR Pharmaceuticals has a 1-year low of $4.30 and a 1-year high of $4.70. The firm’s fifty day moving average is $4.57 and its two-hundred day moving average is $4.59.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.